At a glance
- Originator National Defense Medical Center
- Class Anti-ischaemics; Antiarrhythmics
- Mechanism of Action Adenosine A1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias; Myocardial ischaemia
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Arrhythmias in Taiwan (Unknown route)
- 01 Sep 1998 No-Development-Reported for Myocardial ischaemia in Taiwan (Unknown route)
- 01 Aug 1995 Preclinical development for Arrhythmias in Taiwan (Unknown route)